| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,938 |
3,055 |
$129K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,545 |
2,017 |
$121K |
| S8301 |
Infection control supplies, not otherwise specified |
3,894 |
2,980 |
$72K |
| 87428 |
|
875 |
763 |
$49K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
434 |
408 |
$31K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
408 |
391 |
$29K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,749 |
1,173 |
$26K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
434 |
366 |
$17K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
82 |
74 |
$7K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
781 |
621 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
71 |
70 |
$6K |
| 0001A |
|
112 |
110 |
$4K |
| 0002A |
|
94 |
93 |
$4K |
| 0071A |
|
96 |
91 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
121 |
111 |
$3K |
| 90461 |
|
544 |
466 |
$3K |
| 0072A |
|
75 |
73 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
232 |
212 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
78 |
75 |
$2K |
| 87807 |
|
240 |
212 |
$2K |
| 99000 |
|
173 |
147 |
$2K |
| 0003A |
|
26 |
26 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
96 |
53 |
$879.83 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
76 |
72 |
$728.49 |
| 99051 |
|
242 |
203 |
$627.48 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
14 |
14 |
$625.10 |
| 69210 |
|
23 |
12 |
$585.19 |
| 0111A |
|
13 |
13 |
$520.00 |
| 92552 |
|
38 |
38 |
$473.59 |
| 92551 |
|
31 |
30 |
$201.87 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17 |
15 |
$184.16 |
| 90686 |
|
444 |
441 |
$147.22 |
| 83655 |
|
12 |
12 |
$80.34 |
| 85018 |
|
56 |
55 |
$41.96 |
| 96160 |
|
98 |
85 |
$15.75 |
| 3008F |
|
491 |
475 |
$0.00 |
| 90698 |
|
129 |
117 |
$0.00 |
| 90680 |
|
13 |
12 |
$0.00 |
| 3074F |
|
280 |
268 |
$0.00 |
| 36416 |
|
78 |
71 |
$0.00 |
| 96127 |
|
51 |
36 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
319 |
235 |
$0.00 |
| 90670 |
|
182 |
173 |
$0.00 |
| 90671 |
|
80 |
68 |
$0.00 |
| 99173 |
|
138 |
133 |
$0.00 |
| 90633 |
|
12 |
12 |
$0.00 |